Life science News and Research

RSS

Microfuge 20 and 20R microcentrifuges from Beckman Coulter Life Sciences simplify setup, offer increased speed and capacity

Microfuge 20 and 20R microcentrifuges from Beckman Coulter are designed to meet the specific requirements of a wide range of research applications.

From Beckman Coulter Life Sciences - Centrifugation 17 Jul 2013

One step closer to understanding how to control cancer cells without harming healthy ones

The nasty side effects of radiation and chemotherapy are well known: fatigue, hair loss and nausea, to name a few. Cancer treatment can seem as harsh as the disease because it can't differentiate healthy cells from cancerous cells, killing both.

17 Jul 2013

PathoQuest closes new fundraising of EUR 3.8 million

PathoQuest, a new generation molecular diagnostics company that offers a new approach based on NGS (Next Generation Sequencing) in the field of infectious diseases, announces today the closing of a new fundraising of EUR 3.8 million.

12 Jul 2013

Prolonged exposure to low levels of air pollution boosts lung cancer risk

Prolonged exposure to particulate air pollution increases the risk of lung cancer (particularly adenocarcinoma) even at levels below the European Union limit values, according to one of the largest studies of its kind published in The Lancet Oncology.

11 Jul 2013

Study: ChemoFx chemoresponse assay can help identify platinum resistance in primary ovarian cancer

Precision Therapeutics, a leading life-science company dedicated to the improvement of patient outcomes in personalized medicine, today announced findings that support the ChemoFx chemoresponse assay as a tool to aid in the identification of platinum resistance in primary ovarian cancer, according to a presentation at the Annual Meeting of The Western Association of Gynecologic Oncologists June 26-29, in Seattle, Washington.

8 Jul 2013

CRB Bio II, ADE Capital Sodical commit €3M seed investment round in Raman Health Technologies

CRB Bio II, a VC Fund managed by CRB Inverbío, and ADE Capital Sodical, have committed a €3M seed investment round in Raman Health Technologies, a new start up company developing a new non invasive diagnostic technology platform based on Raman laser and Infrarred spectroscopy. Its first indication will be for the early diagnosis of Alzheimer disease in a blood sample.

3 Jul 2013

Prosigna Breast Cancer Prognostic Gene Signature Assay study published in JCO

NanoString Technologies, Inc., a provider of life science tools for translational research and molecular diagnostic products, today announced that the TransATAC clinical validation study for its Prosigna Breast Cancer Prognostic Gene Signature Assay, which is based on the PAM50 gene signature, was published in the Journal of Clinical Oncology.

From NanoString Technologies 2 Jul 2013

Bioline announces worldwide release of MyTaq Extract-PCR Kit

Bioline, The PCR Company, a wholly-owned subsidiary of Meridian Bioscience, Inc., is proud to announce the worldwide release of the MyTaq Extract-PCR Kit.

2 Jul 2013

Janssen, Johnson & Johnson Innovation establish IBD research alliance with Mount Sinai

Janssen Biotech, Inc. and Johnson & Johnson Innovation announced today the establishment of a research alliance with The Icahn School of Medicine at Mount Sinai to advance the scientific understanding of inflammatory bowel disease and the discovery of next generation therapeutic solutions.

27 Jun 2013

Chemotherapy devices: an interview with Damien Salauze, head of Curie-Cancer

Although several chemotherapy treatments are now administered by the oral route (targeted chemotherapy), most chemotherapy treatments (cytotoxics) are administered by the intravenous route.

13 Jun 2013

Powerful new mass spectrometry systems and solutions for life-science research, clinical research, pharma and applied markets announced by Bruker

At the 61st ASMS Conference on Mass Spectrometry and Allied Topics, Bruker today announced mass spectrometry-based product introductions for life-science and clinical research, for biotech/pharma/CRO customers, as well as for industrial and applied markets. The new mass spectrometry systems and solutions are designed to deliver confident analyses with dramatically enhanced resolution, sensitivity and precision.

10 Jun 2013

Novel method introduced for detecting retinal micro-aneurysms that pose high risk for leakage

Yissum Research Development Company of the Hebrew University of Jerusalem Ltd., the technology transfer arm of the Hebrew University, introduces a novel method for detecting retinal micro-aneurysms that pose a high risk for leakage, an underlying cause of diabetic retinopathy.

10 Jun 2013

Weather may influence transmission of West Nile, chikungunya, and other viral disease

Urban epidemics resulting from viral diseases, such as West Nile fever and chikungunya fever, are transmitted by infected mosquitoes.

4 Jun 2013

Allenex to sell its holding in AnaMar AB to Koncentra Holding

Allenex has agreed to sell its holding in AnaMar AB to the company's main owner Koncentra Holding. The price is set to 1,7 mkr. Allenex became an owner in AnaMar 1998.

3 Jun 2013

NanoString's Prosigna Breast Cancer Assay can help identify node-positive early-stage breast cancer

NanoString Technologies, Inc., a privately held provider of life science tools for translational research and molecular diagnostic products, today announced new results from the combined data analysis of the Austrian Breast & Colorectal Cancer Study Group 8 (ABCSG-8) and Arimidex, Tamoxifen, Alone or in Combination studies.

From NanoString Technologies 3 Jun 2013

Patients with type 2 diabetes have altered gut microbiota

Intestinal bacteria may have a greater influence on us than was previously thought. In a study published in the prestigious journal Nature on 29 May, researchers at the Sahlgrenska Academy, University of Gothenburg, Sweden and Chalmers University of Technology, Sweden, show that patients with type 2 diabetes have an altered gut microbiota.

3 Jun 2013

NanoString Technologies to present clinical study of Prosigna Breast Cancer Assay at ASCO 2013

NanoString Technologies, Inc., a privately held provider of life science tools for translational research and molecular diagnostic products, today announced that a clinical study of the Prosigna Breast Cancer Assay will be presented during the Breast Cancer Oral Abstract Session at the 2013 Annual American Society of Clinical Oncology Meeting on Sunday, June 2.

From NanoString Technologies 1 Jun 2013

Life science News and Research

Microfuge 20 and 20R microcentrifuges from Beckman Coulter Life Sciences simplify setup, offer increased speed and capacity

One step closer to understanding how to control cancer cells without harming healthy ones

PathoQuest closes new fundraising of EUR 3.8 million

Prolonged exposure to low levels of air pollution boosts lung cancer risk

Study: ChemoFx chemoresponse assay can help identify platinum resistance in primary ovarian cancer

CRB Bio II, ADE Capital Sodical commit €3M seed investment round in Raman Health Technologies

Prosigna Breast Cancer Prognostic Gene Signature Assay study published in JCO

Bioline announces worldwide release of MyTaq Extract-PCR Kit

Janssen, Johnson & Johnson Innovation establish IBD research alliance with Mount Sinai

Chemotherapy devices: an interview with Damien Salauze, head of Curie-Cancer

Powerful new mass spectrometry systems and solutions for life-science research, clinical research, pharma and applied markets announced by Bruker

Novel method introduced for detecting retinal micro-aneurysms that pose high risk for leakage

Weather may influence transmission of West Nile, chikungunya, and other viral disease

Allenex to sell its holding in AnaMar AB to Koncentra Holding

NanoString's Prosigna Breast Cancer Assay can help identify node-positive early-stage breast cancer

Patients with type 2 diabetes have altered gut microbiota

NanoString Technologies to present clinical study of Prosigna Breast Cancer Assay at ASCO 2013

New research shows uremic toxins increase heart attack risk

Chromatrap® ChIP assay kit enriches epigenetic marks from primary human tissue cells

Video demonstrating a SPE microplate method for reproducible isolation of high quality RNA released by INTEGRA

Ultimate guide to the essential tools for the characterization of proteins, polymers and nanoparticles eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News